FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the
<i>BRAF</i>
V600 Mutation

FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAF V600 Mutation

Oneal, Patricia A.; Kwitkowski, Virginia; Luo, Lola; Shen, Yuan Li; Subramaniam, Sriram; Shord, Stacy; Goldberg, Kirsten B.; McKee, Amy E.; Kaminskas, Edvardas; Farrell, Ann; Pazdur, Richard

期刊名称The Oncologist
作者Oneal, Patricia A.; Kwitkowski, Virginia; Luo, Lola; Shen, Yuan Li; Subramaniam, Sriram; Shord, Stacy; Goldberg, Kirsten B.; McKee, Amy E.; Kaminskas, Edvardas; Farrell, Ann; Pazdur, Richard
印刷ISSN1083-7159
电子ISSN1549-490X
文件大小160.92KB
发表时间2018-08-17
DOI10.1634/theoncologist.2018-0295

发现好书期刊，享受阅读乐趣

FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim‐Chester Disease with the BRAF V600 Mutation